AI's Impact on Health Data Diversity
Published on:
Share this post

Article Summary
Summary of Key Points:
Global Diabetes Statistics:
- Over 10% of adults worldwide live with diabetes, with projections of 125 million individuals in India by 2045.
- South Asians face higher risks and earlier onset of diabetes compared to other populations.
Genetic Research Bias:
- A significant lack of diversity exists in genomic datasets, with over 86% of genetic studies focused on European ancestry, and South Asians representing less than 1% in critical databases such as the NHGRI-EBI GWAS Catalogue (2005-2025).
- This underrepresentation hampers the development of accurate predictive models and tailored healthcare solutions for South Asians.
Health Disparities:
- South Asians are disproportionately affected by diseases such as type 2 diabetes, cardiovascular disease, and asthma.
- Polygenic risk scores derived from European datasets are less effective when applied to South Asian health, indicating the need for localized genetic data.
Diverse Genetic Landscape:
- Research indicates that South Asia has one of the world's most genetically diverse human populations, yet many studies fail to consider this diversity.
- The GenomeIndia Project, launched in 2020, aims to document genetic variations unique to Indian populations and has already identified over 40 million variants.
Need for Localized Research:
- Current health research funding and biobanking efforts in low- and middle-income countries (LMICs) are inadequate. Only about 10% of global health research funding focuses on health needs in LMICs, despite them experiencing over 90% of potential years of life lost.
- There's a call for increased funding, infrastructure, and collaboration among South Asian countries for effective genomics research.
Policy Recommendations:
- A recent perspective from the Lancet Regional Health urges government and health institutions in South Asia to prioritize building local infrastructures for genomic research.
- Recommendations include regional collaborations among biobanks and establishing systems that allow data sharing across populations.
Judicial and Ethical Implications:
- The underrepresentation of South Asian health data raises ethical concerns regarding equitable health access and rights, highlighting the need for policies that ensure all demographics are adequately represented in health research.
Technological Developments:
- The use of artificial intelligence and machine learning can enhance disease detection and treatment personalization, but this efficacy relies heavily on the availability of diverse and comprehensive datasets.
Health Policy Implications:
- There is a necessity for diagnostics, risk assessments, and treatment protocols to be validated and recalibrated based on South Asian data to improve healthcare outcomes.
Cooperation for Futures:
- Establishing a cooperative framework among South Asian nations is vital to prevent exclusion from genomic advancements, ensuring that local researchers are integral to any research involving their populations.
These observations underscore the importance of localized research efforts and equitable health policies that address the unique genetic and health profiles of South Asian populations.
Key Terms & Concepts
| Diabetes prevalence | Affects South Asian adults massively |
| 125 million | Projected diabetes cases in India by 2045 |
| U.K. Biobank | Integrated biobank for research |
| NHGRI-EBI GWAS Catalogue | Database for genome-wide association studies |
| 2005-2025 | Timeframe for study participant data |
| 20% | Neglected global population in data |
| Cell Genomics | Published study on sample representation |
| Polygenic risk scores | Estimates genetic risk for diseases |
| GenomeIndia Project | Captures India's genetic diversity |
| 40 million | Unique genetic variants found |
| 90% | Global years of life lost in LMICs |
| GenomeIndia, Phenome India, Longevity India | Large prospective cohorts in India |

